About the seminar
This seminar and webcast will cover the practical issues that arise when handling licences of patents, trademarks and copyrights (including software), particularly in a cross-border context, including:
- Allocation of risk: Representations, warranties, indemnification, and limitations on liability
- Ownership of improvements
- Effects of bankruptcy
- Source code escrow arrangements
- Restrictions on transfer and "divested entity" provisions
- Confidentiality obligations
- Obligations to exploit
- Financial terms
- Rights on termination
- Daniel Glazer is a partner in Fried, Frank, Harris, Shriver & Jacobson LLP's New York office and the co-leader of the firm's Technology Transactions Group.
Dan has extensive experience structuring and negotiating complex domestic and cross-border intellectual property and information technology transactions. He regularly advises on IP, technology and commercial issues for a range of companies – from foundation-stage companies (particularly in New York and the UK) to Fortune 50 corporations – in industries such as telecommunications, financial services, consumer products, pharmaceuticals, food and beverage, media and entertainment, and sports.
Dan's practice includes all types of IP and technology-focused commercial agreements, such as licensing, outsourcing, development, consulting, manufacturing, supply, sponsorship, marketing, distribution and transfer arrangements, as well as the IP/IT aspects of mergers and acquisitions, joint ventures, securitizations, credit arrangements and other complex corporate transactions. His practice also includes trademark and copyright counseling, enforcement and portfolio development.
- Dr Luke Kempton has a PhD in biochemistry, re-qualified as a solicitor in 1994 and joined Wragge & Co in 1996. He leads the transactional IP team at Wragge & Co LLP. He has acted on numerous international collaboration and licensing deals, as well as significant M&A transactions and investments in many areas of technology, with a particular focus on the life sciences. He also advises on all types of agreements related to the pharmaceutical sector including clinical trial agreements, MTAs, manufacturing and supply agreements, CDAs and co-promotion agreements and has also acted for several research institutions on the creation of spin out companies. He is an expert on IP due diligence in the context of licence and product acquisition transactions as well as M&A deals. He is noted by Chambers 2010 as being an "extremely talented lawyer" and is commended for his "scientific understanding" (Legal 500 2011).
10 December 2012
- 08.00am: Registration and breakfast
- 08.30am: Seminar begins
- 10.00am: Seminar concludes
Free to attend